Neurology

Ofatumumab sBLA Is Accepted for Treatment of Relapsing Multiple Sclerosis




The novel B-cell therapy has been assigned a PDUFA date of June 2020.

Source link




Related posts

Austin Monthly’s Top Doctors

Newsemia

Infectious Theory of Alzheimer Disease Draws Fresh Interest

Newsemia

Cord Blood Test May Flag Neonatal Hypoxia Risk

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy